# Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy

> **NCT02372708** · — · COMPLETED · sponsor: **Chinese PLA General Hospital** · enrollment: 72 (actual)

## Conditions studied

- Melanoma

## Interventions

- **DRUG:** dinitrophenyl(DNP)
- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT02372708
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2012-05
- **Final completion:** 2014-05
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2015-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02372708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02372708, "Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02372708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*